Spanish private equity firm Corsabe has participated in a capital expansion round in biotechnology company Oryzon, acquiring a 3.5% stake. Ordesa Laboratories also invested for a 3% stake.
Shares are sold by shares were held by CapMan Buyout X Fund A and CapMan Buyout X Fund B
Advent made a takeover offer of 165 pence per share in cash, which represents a 34% premium in July
Business strategy platform will expand its product and triple its team size
Fund targets companies operating in the healthcare industry, primarily pharma, medtech and outsourced services